Susquehanna International Group
SGMO

Susquehanna International Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Susquehanna International Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Sell
461,800
-86,200
-16% -$34.3K ﹤0.01% 12235
2025
Q4 		$230K Sell
548,000
-297,100
-35% -$157K ﹤0.01% 10556
2025
Q3 		$566K Buy
845,100
+278,700
+49% +$150K ﹤0.01% 8682
2025
Q2 		$306K Sell
566,400
-788,100
-58% -$468K ﹤0.01% 10291
2025
Q1 		$894K Buy
1,354,500
+297,200
+28% +$315K ﹤0.01% 7523
2024
Q4 		$1.08M Buy
1,057,300
+384,800
+57% +$703K ﹤0.01% 6760
2024
Q3 		$585K Buy
672,500
+652,800
+3,314% +$478K ﹤0.01% 8090
2024
Q2 		$7.09K Buy
+19,700
New +$10.6K ﹤0.01% 11804
2023
Q1 		– Sell
-26,500
Closed -$83.2K – 13406
2022
Q4 		$83.2K Sell
26,500
-114,200
-81% -$443K ﹤0.01% 11102
2022
Q3 		$689K Buy
140,700
+7,300
+5% +$37.5K ﹤0.01% 7610
2022
Q2 		$552K Sell
133,400
-7,500
-5% -$32.4K ﹤0.01% 8027
2022
Q1 		$819K Sell
140,900
-4,900
-3% -$29.1K ﹤0.01% 7652
2021
Q4 		$1.09M Sell
145,800
-8,200
-5% -$71.2K ﹤0.01% 7060
2021
Q3 		$1.39M Sell
154,000
-93,200
-38% -$921K ﹤0.01% 6684
2021
Q2 		$2.96M Buy
247,200
+6,100
+3% +$69.1K ﹤0.01% 5053
2021
Q1 		$3.02M Sell
241,100
-56,600
-19% -$763K ﹤0.01% 4936
2020
Q4 		$4.65M Sell
297,700
-106,200
-26% -$1.24M ﹤0.01% 3523
2020
Q3 		$3.82M Buy
403,900
+100,600
+33% +$1.09M ﹤0.01% 3460
2020
Q2 		$2.72M Buy
303,300
+69,000
+29% +$640K ﹤0.01% 3970
2020
Q1 		$1.49M Sell
234,300
-443,700
-65% -$3.29M ﹤0.01% 4509
2019
Q4 		$5.67M Buy
678,000
+85,900
+15% +$790K ﹤0.01% 2807
2019
Q3 		$5.36M Sell
592,100
-29,500
-5% -$331K ﹤0.01% 2634
2019
Q2 		$6.7M Sell
621,600
-122,300
-16% -$1.3M ﹤0.01% 2348
2019
Q1 		$7.1M Buy
743,900
+35,700
+5% +$365K ﹤0.01% 2074
2018
Q4 		$8.13M Sell
708,200
-90,600
-11% -$1.13M ﹤0.01% 1792
2018
Q3 		$13.5M Buy
798,800
+145,200
+22% +$2.21M ﹤0.01% 1658
2018
Q2 		$9.28M Buy
653,600
+219,300
+50% +$3.64M ﹤0.01% 2014
2018
Q1 		$8.25M Sell
434,300
-186,900
-30% -$4M ﹤0.01% 1982
2017
Q4 		$10.2M Buy
621,200
+255,800
+70% +$3.81M ﹤0.01% 1811
2017
Q3 		$5.48M Sell
365,400
-82,800
-18% -$915K ﹤0.01% 2388
2017
Q2 		$3.94M Buy
448,200
+227,800
+103% +$1.46M ﹤0.01% 2721
2017
Q1 		$1.15M Buy
220,400
+146,700
+199% +$588K ﹤0.01% 4845
2016
Q4 		$225K Sell
73,700
-1,600
-2% -$5.83K ﹤0.01% 8483
2016
Q3 		$349K Buy
75,300
+1,900
+3% +$9.66K ﹤0.01% 6682
2016
Q2 		$425K Sell
73,400
-35,000
-32% -$223K ﹤0.01% 6398
2016
Q1 		$656K Sell
108,400
-65,100
-38% -$391K ﹤0.01% 5908
2015
Q4 		$1.58M Sell
173,500
-103,700
-37% -$799K ﹤0.01% 4519
2015
Q3 		$1.56M Buy
277,200
+51,200
+23% +$422K ﹤0.01% 4775
2015
Q2 		$2.51M Sell
226,000
-110,400
-33% -$1.42M ﹤0.01% 4217
2015
Q1 		$5.28M Buy
336,400
+12,300
+4% +$190K ﹤0.01% 2667
2014
Q4 		$4.93M Sell
324,100
-17,000
-5% -$206K ﹤0.01% 2909
2014
Q3 		$3.68M Sell
341,100
-25,600
-7% -$334K ﹤0.01% 3521
2014
Q2 		$5.6M Sell
366,700
-92,300
-20% -$1.33M ﹤0.01% 2891
2014
Q1 		$8.3M Buy
459,000
+172,600
+60% +$3.33M ﹤0.01% 2226
2013
Q4 		$3.98M Sell
286,400
-48,600
-15% -$560K ﹤0.01% 3260
2013
Q3 		$3.52M Sell
335,000
-6,900
-2% -$68.5K ﹤0.01% 3237
2013
Q2 		$2.67M Buy
+341,900
New +$2.98M ﹤0.01% 3444

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's SGMO Position: Q1 2026 in Review

Susquehanna International Group reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 21% in Q1 2026, selling an estimated $179K and leaving 1,687,463 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #10115.

Susquehanna International Group first reported a position in SGMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.01M in Q3 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Susquehanna International Group held 1,687,463 shares of SANGAMO THERAPEUTICS INC worth $417K as of Q1 2026.
  • Susquehanna International Group sold 449,657 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $179K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10115 holding.
  • Susquehanna International Group first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 52 quarters since.
  • Susquehanna International Group's SANGAMO THERAPEUTICS INC position peaked at $9.01M in Q3 2018.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.